ArticleAmerican journal of hematology2023

Venous thromboembolism risk in cancer patients receiving first-line immune checkpoint inhibitor versus chemotherapy.

Ang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.